Click a topic below for an index of articles:

 

New-Material

Home

Alternative-Treatments

Financial or Socio-Economic Issues

Forum

Health Insurance

Hepatitis

HIV/AIDS

Institutional Issues

International Reports

Legal Concerns

Math Models or Methods to Predict Trends

Medical Issues

Our Sponsors

Occupational Concerns

Our Board

Religion and infectious diseases

State Governments

Stigma or Discrimination Issues

If you would like to submit an article to this website, email us at info@heart-intl.net for a review of this paper
info@heart-intl.net

 

any words all words
Results per page:

“The only thing necessary for these diseases to the triumph is for good people and governments to do nothing.”

       
     

Management of Cirrhotic Ascites
from Medscape General Medicine [TM]

Treatment of Cirrhotic Ascites
Treating Reversible Causes of Cirrhosis
In 1997, alcoholic liver disease accounted for 40% of deaths from cirrhosis in the United States.[8] One prospective study[9] has shown reduction of portal pressures in somepatients following a period of abstinence from alcohol, with possible resolution of ascites or greater
responsiveness to medical therapy. Irrespective of the etiology of cirrhosis, all patients should be advised to abstain from alcohol completely, including avoidance of alcohol-containing medications and so-called "nonalcoholic" beers.[10]

Bedrest
Bedrest has traditionally been recommended for patients with ascites on the basis that upright
posture increases aldosterone levels, which is associated with sodium retention.[11] Although
bedrest has been shown to increase natriuresis in cirrhotics,[12] there are no data available to
support improvement in clinically relevant outcomes in ascites.[10] Furthermore, prolonged bedrest is impractical, expensive, and difficult to enforce.

Sodium Restriction
Sodium retention is central to the formation of ascites. The typical North American diet contains 200-300 mmol of sodium per day, whereas a no-added-salt diet contains 100-150 mmol of sodium per day. Nonurinary sodium excretion in afebrile cirrhotic patients without diarrhea is approximately 10 mmol/day.[13] Patients with ascites on no diuretics commonly have renal
sodium excretion of < 20 mmol/day. Such a patient on a no-added-salt diet will retain at least 100 mmol of sodium per day and 10 L of fluid in 2 weeks (100 mmol/day x 14 days/140 mmol/L = 10 L).

 

 

All patients with ascites should receive counseling regarding the importance of a low-sodium diet. A diet containing 88 mmol/day is currently recomm ended for patients with
ascites.[14] Diets that have even lower salt contents are not well tolerated. Potassium-containing salt substitutes should be avoided because of the risk of hyperkalemia, especially in those receiving potassium-sparing diuretics. In 10% of patients, sodium restriction alone may be adequate in the control of ascites.[14] Only patients who have urinary excretions of > 78 mmol/day should be treated with sodium restriction alone. In patients with severely impaired natriuresis and difficult-to-control ascites, sodium restriction of 44 mmol per day or even 22 mmol per day may be required.

Most experts believe that dietary sodium restriction is essential to the effective management of
ascites. Trials of sodium restriction vs unrestricted diet among patients on diuretics have not
shown significant benefits, but have been shown to decrease the time to complete resolution of
ascites.[15] One study has shown that compliance with a low-sodium diet can significantly decrease diuretic requirements.[16]

Fluid Restriction
Fluid loss usually follows sodium loss; therefore, fluid restriction in patients with ascites is
usually not required. Cirrhotic patients with ascites often have hyponatremia, which is a reflection of severe intravascular volume contraction. In most instances, hyponatremia responds to volume replacement with colloid, and fluid restriction should only be used in patients with serum sodium < 120 mmol/L.

Diuretics
Diuretics that block aldosterone receptors in the distal convoluted tubule are preferred because of the presence of hyperaldosteronism in patients with cirrhosis. Loop diuretics may be used in
combination, but are ineffective when used alone. The initial starting dose of spironolactone is 100 mg once daily and can be titrated up to a maximum of 400 mg once a day. Absorption of spironolactone is improved if administered with food. The diuretic effect can be seen
within 48 hours, but the peak onset of action is 2 weeks, due to impaired metabolism in cirrhotic persons and a half-life of up to 5 days.[17] Therefore, the dose should be adjusted only once a week. Side effects include hyperkalemia and painful gynecomastia. Amiloride can be used instead of spironolactone, starting at 5 mg per day. The latter is sometimes preferred because of its shorter half-life and quicker onset of action. However, it is much more expensive than spironolactone and has also been shown to be less effective in a randomized, controlled trial.[18]

 



Both spironolactone and amiloride are weak diuretics and often require the addition of a loop
diuretic such as furosemide. Furosemide effects are evident within 30 minutes of oral administration, with a peak effect within 1-2 hours and a duration of action of 4 hours. It is a potent diuretic but is not as effective as spironolactone alone.[19] Furosemide prevents reabsorption of sodium in the loop of Henle; without spironolactone, however, sodium delivered to the distal collecting duct is rapidly reabsorbed due to unopposed aldosterone action. Side effects of furosemide include hypokalemia, hypovolemia, hyponatremia, and increased
renal ammonia production. Hypokalemia is usually not a problem when furosemide is combined
with a potassium-sparing diuretic. Intravenous administration of furosemide is not
recommended because of good oral availability and because of the potential for causing acute
reductions in GFR.[20,21] There is no advantage to using other loop diuretics. The usual starting doses of diuretics are 100 mg of spironolactone and 40 mg furosemide.[14] Doses can be titrated up to a maximum of 400 mg of spironolactone and 160 mg of furosemide. A ratio of 100:40 usually maintains normokalemia.

Monitoring Response to Sodium Restriction and Diuretics Compliance with and response to sodium restriction and diuretics can be evaluated by daily weights and 24-hour urine collection for sodium. Completeness of urine collection is indicated by urinary creatinine levels of 15-20 mg/kg in males and 10-15 mg/kg in females.[10] Weight loss should be limited to 0.5 kg per day. More rapid weight loss can cause hypovolemia and renal insufficiency, as fluid resorption from the peritoneal cavity is limited to 700 mL per day.[22] Patients with massive edema can tolerate more rapid fluid loss until the edema has resolved.

In order for a patient with a serum sodium concentration of 140 mmol/L on an 88-mmol/day diet to lose 0.5 kg/day or 0.5 L of fluid, the 24-hour urine collection should contain approximately 150 mmol of sodium (140 mmol/Lx 0.5 L + 78 mmol/day). If a 24-hour urine collection is not possible, a random urine sodium-to-potassium ratio of > 1 predicts a > 78-mmol/day sodium excretion in 90% of patients.[23] Noncompliance with a low-sodium diet is reflected by an adequate sodium excretion but with the patient not losing weight. Inadequate sodium excretion, on the other hand, necessitates increasing the doses of diuretics as tolerated up to the maximum recommended level. Diuretics should be discontinued and consideration should be given to the use of second-line therapy if there is evidence of encephalopathy, if serum sodium is < 120 mmol/L despite fluid restriction, or if serum creatinine is > 2.0 mg/dL (180 micromoles [mcmol]/day).[10]

Large-volume paracentesis, if performed for tense nonrefractory ascites, should be followed by
diuretics to prevent reaccumulation of fluid. In a study of 36 patients treated by total
paracentesis plus intravenous albumin randomized to receive spironolactone 225 mg/day vs placebo, only 18% of those receiving spironolactone had recurrence of ascites
compared with 93% of those in the placebo group (P < .0001).[24] The use of 225 mg/day of spironolactone was shown to be effective and safe in most cases, without increased incidence of postparacentesis circulatory dysfunction. Patients should also continue to observe sodium restriction.